Anika Therapeutics, Inc. (ANIK) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -4.85M | 4.64M | 6.87M | -189K | -130K | 1.58M | 5.02M | -1.07M | -126K | 3.64M | 6.49M | -8.29M |
| Operating CF Margin % | -16.36% | 15.15% | 24.7% | -0.67% | -0.5% | -122.64% | 12.94% | -3.48% | -0.31% | 8.47% | 15.64% | -18.72% |
| Operating CF Growth % | -3627.69% | 193.11% | 36.96% | 82.32% | -3.17% | -56.51% | -22.65% | 87.11% | 96.52% | 656.34% | 139.39% | -368.56% |
| Net Income | -5.06M | 292K | -2.33M | -3.97M | -4.87M | -21.86M | -29.92M | -88K | -1.96M | -63M | -6.58M | -2.74M |
| Depreciation & Amortization | 1.41M | 1.32M | 1.4M | 1.42M | 1.59M | 1.81M | 2.19M | 2.06M | 2.06M | 3.59M | 3.54M | 4.15M |
| Stock-Based Compensation | 6.64M | 2.46M | 2.21M | 2.55M | 2.86M | 2.25M | 3.39M | 3.89M | 0 | 3.81M | 3.56M | 0 |
| Deferred Taxes | 108K | -25K | 3K | -3K | 18K | 234K | -184K | 17K | 193K | -1.84M | -1.21M | -904K |
| Other Non-Cash Items | 1.24M | 1.73M | 1.17M | 3.65M | 539K | 21.51M | 28.04M | 1.09M | 3.75M | 63.69M | 3.73M | 4.8M |
| Working Capital Changes | -9.19M | -1.13M | 4.41M | -3.83M | -269K | -2.36M | 1.49M | -8.04M | -4.18M | -2.61M | 3.44M | -13.59M |
| Change in Receivables | -2.18M | -1.54M | 1.29M | -2.38M | 3.03M | -3.27M | 4.78M | -1.76M | 3.62M | -1.1M | 1.92M | -6.17M |
| Change in Inventory | -5.41M | -1.78M | -443K | 1.73M | 523K | 2.39M | -3M | -4.72M | -4.09M | -3.14M | -2.1M | -3.09M |
| Change in Payables | 745K | 877K | 231K | -1.11M | 47K | -121K | -2.93M | 148K | 401K | 1.31M | -290K | -316K |
| Cash from Investing | -1.24M | 198K | -1.73M | -539K | 1.67M | -1.31M | -1.82M | -3.4M | -1.81M | -1.84M | -741K | -1.46M |
| Capital Expenditures | -1.43M | -648K | -1.89M | -1.47M | -2.82M | -1.31M | -1.22M | -3.4M | -1.81M | -1.84M | -741K | -1.46M |
| CapEx % of Revenue | 4.83% | 2.12% | 6.78% | 5.2% | 10.79% | -101.32% | 3.14% | 11.08% | 4.46% | 4.28% | 1.79% | 3.29% |
| Acquisitions | 0 | 4.5M | 0 | 0 | 4.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 192K | -3.65M | 155K | 928K | 0 | 0 | -600K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -10.35M | -5.28M | -13K | 179K | -5.44M | -5.35M | -3.99M | -1.11M | -2.27M | 342K | -110K | -4.94M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | -8.69M | -5.28M | 0 | 261K | -3.97M | -5.58M | -3.97M | -906K | 23K | 335K | -110K | -4.51M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -8.69M | -5.51M | 0 | 0 | -3.97M | -5.58M | -3.97M | -1.37M | 0 | 0 | -110K | -5M |
| Other Financing | -1.66M | -4K | -13K | -82K | -1.47M | 221K | -22K | -205K | -2.3M | 7K | 0 | -429K |
| Net Change in Cash | -16.46M | -509K | 4.82M | -204K | -3.79M | -5.21M | -454K | -5.81M | -111K | 2.22M | 5.58M | -14.67M |
| Free Cash Flow | -6.28M | 3.99M | 4.98M | -1.66M | -2.95M | 275K | 3.2M | -4.47M | -1.93M | 1.8M | 5.74M | -9.75M |
| FCF Margin % | -21.2% | 13.03% | 17.91% | -5.87% | -11.29% | -21.32% | 8.26% | -14.56% | -4.77% | 4.18% | 13.85% | -22.01% |
| FCF Growth % | -112.49% | 1350.55% | 55.72% | 62.97% | -52.74% | -84.71% | -44.29% | 54.13% | 61.37% | 187.79% | 464.24% | -949.3% |
| FCF per Share | -0.46 | 0.27 | 0.35 | -0.12 | -0.21 | 0.02 | 0.22 | -0.30 | -0.13 | 0.12 | 0.39 | -0.66 |
| FCF Conversion (FCF/Net Income) | 0.96x | 15.88x | -2.95x | 0.05x | 0.03x | -0.07x | -0.17x | 12.15x | 0.03x | -0.06x | -0.99x | 3.03x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |